Platform
Features
0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Employees
Links
Hugh Y. Rienhoff, Jr.
15 members
9 members
5 members
4 members
3 members
Spero Therapeutics
2 followers
Aizon
4 followers
The Bay School of San Francisco
1 follower
Invaio Sciences
TopstepTrader
Thermo Fisher Scientific
167 followers
Genentech
150 followers
Biogen
115 followers
Regeneron
94 followers
Guild
33 followers
McGraw-Hill
24 followers
Explore companies